 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              Integrated Core Strategies Asia Ptd Ltd has sold 18,30,093 shares of Glenmark Pharmaceuticals Ltd through bulk deal in NSE. The shares were sold at a price of Rs. 329.57 per share.
Shares of GLENMARK PHARMACEUTICALS LTD. was last trading in BSE at Rs.332.05 as compared to the previous close of Rs. 337.55. The total number of shares traded during the day was 154210 in over 4280 trades.
The stock hit an intraday high of Rs. 340 and intraday low of 326.2. The net turnover during the day was Rs. 50969157.